Cipla | CIPLA - Cash And Equivalent

Stock Price
1,332.70
Daily Change
6.00 0.45%
Monthly
-12.94%
Yearly
-9.43%
Q1 Forecast
1,299.11

Cipla reported INR7.96B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
aTyr Pharma USD 6.15M 11.07M Sep/2025
Cipla INR 7.96B 39.9M Sep/2025
Dr.Reddys Laboratories INR 18.66B 8.75B Dec/2025
Sun Pharmaceuticals INR 113.32B 33.19B Mar/2025
UPL INR 41.52B 53.85B Sep/2025